Provided by Tiger Fintech (Singapore) Pte. Ltd.

uniQure NV

14.69
+0.29002.01%
Volume:215.85K
Turnover:3.16M
Market Cap:804.26M
PE:-3.36
High:14.87
Open:14.48
Low:14.31
Close:14.40
Loading ...

Stock Track | uniQure NV Soars 5.47% Pre-Market on Better-Than-Expected Q1 Results

Stock Track
·
09 May

Uniqure NV reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
09 May

uniQure Q1 EPS $(0.82) Beats $(0.95) Estimate, Sales $1.57M Miss $6.27M Estimate

Benzinga
·
09 May

uniQure recent selloff overdone, says H.C. Wainwright

TIPRANKS
·
09 May

Uniqure NV expected to post a loss of $1.01 a share - Earnings Preview

Reuters
·
07 May

uniQure to Announce First Quarter 2025 Financial Results

GlobeNewswire
·
06 May

Leerink Partners Remains a Buy on uniQure (QURE)

TIPRANKS
·
30 Apr

CG Oncology, Inc. (CGON) Surges 25.0%: Is This an Indication of Further Gains?

Zacks
·
29 Apr

uniQure Price Target Maintained With a $70.00/Share by HC Wainwright & Co.

Dow Jones
·
22 Apr

H.C. Wainwright Sticks to Its Buy Rating for uniQure (QURE)

TIPRANKS
·
22 Apr

Analysts Offer Insights on Healthcare Companies: Neogen (NEOG) and uniQure (QURE)

TIPRANKS
·
22 Apr

uniQure (QURE) Moves 38.5% Higher: Will This Strength Last?

Zacks
·
21 Apr

Top Premarket Gainers

MT Newswires Live
·
17 Apr

UniQure Shares Soar After Latest FDA Designation for Huntington's Disease Treatment

Dow Jones
·
17 Apr

UniQure's Huntington's Drug Gets FDA Breakthrough Therapy Designation

MT Newswires Live
·
17 Apr

Uniqure Announces FDA Breakthrough Therapy Designation Granted To Amt-130 For The Treatment Of Huntington’S Disease

Reuters
·
17 Apr

uniQure Announces FDA Breakthrough Therapy Designation Granted to AMT-130 for the Treatment of Huntington’s Disease

GlobeNewswire
·
17 Apr

uniQure Is Maintained at Buy by Chardan Capital

Dow Jones
·
01 Apr

uniQure transferred with a Buy at Chardan

TIPRANKS
·
01 Apr

Analysts Have Conflicting Sentiments on These Healthcare Companies: AnaptysBio (ANAB), Cytokinetics (CYTK) and uniQure (QURE)

TIPRANKS
·
06 Mar